These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9885452)

  • 41. Health technology adoption and the politics of governance in the UK.
    Milewa T
    Soc Sci Med; 2006 Dec; 63(12):3102-12. PubMed ID: 16982120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Social and ethical analysis in health technology assessment.
    Tantivess S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S81-6. PubMed ID: 24964703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
    Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
    Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of quantitative policy analysis in HIV prevention technology transfer.
    Holtgrave DR
    Public Health Rep; 2004; 119(1):19-22. PubMed ID: 15147644
    [No Abstract]   [Full Text] [Related]  

  • 45. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health technology assessment in Australia: a role for clinical registries?
    Scott AM
    Aust Health Rev; 2017 Mar; 41(1):19-25. PubMed ID: 27028134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Which are the best information sources for identifying emerging health care technologies? An international Delphi survey.
    Robert G; Gabbay J; Stevens A
    Int J Technol Assess Health Care; 1998; 14(4):636-43. PubMed ID: 9885453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early identification and assessment of new and emerging health technologies: actions, progress, and the future direction of an international collaboration--EuroScan.
    Simpson S; Packer C; Carlsson P; Sanders JM; Ibarluzea IG; Fay AF; Norderhaug I
    Int J Technol Assess Health Care; 2008; 24(4):518-25. PubMed ID: 18828949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Technology assessment in health care: methodological and operational questions].
    Krauss-Silva L
    Cad Saude Publica; 2004; 20 Suppl 2():S199-207. PubMed ID: 15608934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland.
    Schmitz S; McCullagh L; Adams R; Barry M; Walsh C
    Pharmacoeconomics; 2016 Sep; 34(9):925-37. PubMed ID: 27034245
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffusion of electronic health records--six years of empirical data.
    Nøhr C; Andersen SK; Bernstein K; Bruun-Rasmussen M; Vingtoft S
    Stud Health Technol Inform; 2007; 129(Pt 2):963-7. PubMed ID: 17911858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The uses of modern technologies: problems and perspectives for industrialized and developing countries.
    Banta D
    Bull Pan Am Health Organ; 1984; 18(2):139-50. PubMed ID: 6487871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation criteria to assess the value of identification sources for horizon scanning.
    Smith J; Cook A; Packer C
    Int J Technol Assess Health Care; 2010 Jul; 26(3):348-53. PubMed ID: 20584366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Historical development of health technology assessment in Thailand.
    Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thai health technology assessment guideline development.
    Teerawattananon Y; Chaikledkaew U
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S11-5. PubMed ID: 19253483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seeing the NICE side of cost-effectiveness analysis: a qualitative investigation of the use of CEA in NICE technology appraisals.
    Bryan S; Williams I; McIver S
    Health Econ; 2007 Feb; 16(2):179-93. PubMed ID: 16960851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transfer of technology assessment to health policy makers.
    Blanpain JE
    Int J Technol Assess Health Care; 1986; 2(1):117-25. PubMed ID: 10276245
    [No Abstract]   [Full Text] [Related]  

  • 59. At the center of health care policy making: the use of health technology assessment at NICE.
    Stevens AJ; Longson C
    Med Decis Making; 2013 Apr; 33(3):320-4. PubMed ID: 23519880
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.